| [1] |
Zhang ZL,Li Q,Du SM,et al.Research status of pharmacokinetic- pharmacodynamic model and its challenges facing to application in traditional Chinese medicine field[J].Chin Tradit Herbal Drugs(中草药),2013,44(2):121-127.
|
| [2] |
Liu CX.Development and overview of pharmacokinetics study for fifty years[J].J Tianjin Univ Tradit Chin Med(天津中医药大学学报),2008,27(3):127-134.
|
| [3] |
Ren XY,Chen YC,Yan W,et al.Pharmacokinetic-pharmacodynamic(PK-PD)modeling of salvianolic acid A on the plasma homocysteine in rats[J].J China Pharm Univ(中国药科大学学报),2012,43(3):260-265.
|
| [4] |
Li H,Zhang Y,Yu YP,et al.Pharmacokinetic/pharmacodynamic modeling of antipyretic and reducing plasma concentration of NO effects of rheum palmatum in rat[J].Chin J Chin Mater Med(中国中药杂志),2013,38(8):1231-1236.
|
| [5] |
Tian L,Di L,Zhou W,et al.Thinking about applied research for integrated PK-PD model of traditional Chinese medicine multiple components′ network target effect[J].World Sci Technol Mod Tradit Chin Med(世界科学技术:中医药现代化),2012,14(4):1824-1830.
|
| [6] |
Braunwald E.Heart failure[J].Jacc Heart Failure,2013,1(1):1-20.
|
| [7] |
Huang XS,Zhao SP,He DR.The correct cognition about surrogate end-points during clinical decision making for cardiovascular diseases[J].Med Philos(医学与哲学),2007,28(4):7-8.
|
| [8] |
Wu DH,Qiu XH,Zhu W,et al.Study on mechanism of clearing-heat herbs on coronary disease in molecular level by network pharmacology[J].Chin J Tradit Chin Med Pharm(中华中医药杂志),2011,26(5):1004-1008.
|
| [9] |
Li X,He H,Liu Y,et al.Effect of salvianolic acid A on uric acid metabolism in acute myocardial infarction rats[J].J China Pharm Univ(中国药科大学学报),2014,45(3):335-340.
|
| [10] |
Wang SB,Tian S,Fan Y,et al.Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats[J].Eur J Pharmacol,2009,615(1/2/3):125-132.
|
| [11] |
He H,Li X,Wang H,et al.Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction[J].J Cardiovasc Pharm,2013,61(6):482-488.
|
| [12] |
Jiang B,Li D,Deng Y,et al.Salvianolic acid A,a novel matrix metalloproteinase-9 inhibitor,prevents cardiac remodeling in spontaneously hypertensive rats[J].PLoS One,2013,8(3):e59621.
|
| [13] |
Ky B,French B,Levy WC,et al.Multiple biomarkers for risk prediction in chronic heart failure[J].Circ-Heart Fail,2012,5(2):183-190.
|
| [14] |
Jiang HY,Yan YD,Liu HC,et al.Evaluation of cardiotoxicity of doxorubicin in rat by a novel metabolic balance model[J].J China Pharm Univ(中国药科大学学报),2015,46(2):224-229.
|
| [15] |
Fertin M, Dubois E, Belliard A, et al. Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction[J].Am J Cardiol,2012,110(2):277-283.
|
| [16] |
He H,Wang S,Li X,et al.A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction[J].Metabolism,2013,62(10):1357-1366.
|
| [17] |
Ken S,Bari M,Satsuki F,et al.Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion:distribution,dynamics,and influence on cardiac function[J].Circulation,2004,110(11Suppl1):225-230.
|
| [18] |
Alhenc-Gelas F,Boudy N,Gobeil FJ,et al.Methods and pharmaceutical compositions for prevention or treatment of ischemia related organ damage:WO,2013144113 A1[P].2013.
|
| [19] |
Zhang W,He H,Wang H,et al.Activation of transsulfuration pathway by salvianolic acid a treatment:a homocysteine-lowering approach with beneficial effects on redox homeostasis in high-fat diet-induced hyperlipidemic rats[J].Nutr Metab,2013,10(11):68.
|
| [20] |
Qiang G,Yang X,Shi L,et al.Antidiabetic effect of salvianolic acid A on diabetic animal models via AMPK activation and mitochondrial regulation[J].Cell Physiol Biochem,2015,36(1):395-408.
|
| [21] |
Chang BB,Zhang L,Cao WW,et al.Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats[J].Acta Pharmacol Sin,2010,31(5):638-646.
|
| [22] |
Hasi'c S,Hadovi'c -Duvo A,Jadri'c R,et al.B-type natriuretic peptide and adiponectin releases in rat model of myocardial damage induced by isoproterenol administration[J].Bosnian J Basic Med,2013,13(4):225-229.
|
| [23] |
Gaggin HK,Januzzi JL.Biomarkers and diagnostics in heart failure[J].Biochimica Et Biophysica Acta,2013,1832(12):2442-2450.
|
| [24] |
Ma TKW,Kam KKH,Yan BP,et al.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases:current status[J].Brit J Pharmacol,2010,160(6):1273-1292.
|
| [25] |
Luchner A,Stevens TL,Borgeson DD,et al.Angiotensin II in the evolution of experimental heart failure[J].Hypertension,1996,28(3):472-477.
|
| [26] |
Maccarthy PA,Shah AM.Oxidative stress and heart failure[J].Mol Cell Biochem,2003,14(2):109-113.
|
| [27] |
Polidori MC,Savino K,Alunni G,et al.Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients:relationship to disease severity[J].Free Radic Biol Med,2002,32(2):148-152.
|
| [28] |
Radovanovic S,Savic-Radojevic A,Pljesa-Ercegovac M,et al.Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure[J].J Card Fail,2012,18(6):493-501.
|
| [29] |
Dückelmann C,Mittermayer F,Haider DG,et al.Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure[J].Arterioscl Throm Vas,2007,27(9):2037-2042.
|
| [30] |
Members WC,O′Gara PT,Kushner FG,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction[J].J Am Coll Cardiol,2013,61(1):e78-e140.
|
下载:
